[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337616-105":59,"doc-detail-337616-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","role-and-mechanism-of-col3a1-in-regulating-the-growth-metastasis-and-drug-sensitivity-in-cisplatin-resistant-non-small-cell-lung-cancer-cells","Role and mechanism of COL3A1 in regulating the growth, metastasis, and drug sensitivity in cisplatin-resistant non-small cell lung cancer cells","","Non-small cell lung cancer (NSCLC) remains difficult to treat, particularly when resistant to cisplatin (DDP). The study investigates how type III collagen COL3A1 contributes to disease progression and chemoresistance by characterizing COL3A1 dysregulation in NSCLC. Bioinformatics, quantitative PCR, immunoblotting, and immunohistochemistry assess upstream regulators and molecular changes. Functional assays evaluate growth, invasion, migration, apoptosis, and DDP sensitivity. Mechanistic validation links YY1-driven transcription to COL3A1 expression, supported by RBPs and in vivo xenograft results, highlighting COL3A1 as a potential therapeutic target.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/role-and-mechanism-of-col3a1-in-regulating-the-growth-metastasis-and-drug-sensitivity-in-cisplatin-resistant-non-small-cell-lung-cancer-cells/337616/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/role-and-mechanism-of-col3a1-in-regulating-the-growth-metastasis-and-drug-sensitivity-in-cisplatin-resistant-non-small-cell-lung-cancer-cells/337616.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of the research paper?","Question",{"text":112,"@type":113},"The paper examines how COL3A1 regulates growth, metastasis, and drug sensitivity in cisplatin-resistant NSCLC cells, including the molecular mechanism behind its dysregulation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is COL3A1 expression related to cisplatin resistance in NSCLC?",{"text":117,"@type":113},"COL3A1 shows enhanced expression in DDP-resistant NSCLC, and reducing COL3A1 inhibits growth, invasion, and migration while increasing DDP sensitivity and apoptosis.",{"name":119,"@type":110,"acceptedAnswer":120},"Which molecular regulators are implicated in controlling COL3A1?",{"text":121,"@type":113},"ELAVL1 enhances COL3A1 mRNA stability and expression, while YY1 promotes COL3A1 transcription and expression; increasing COL3A1 can counteract ELAVL1 inhibition or YY1 deficiency effects.",{"name":123,"@type":110,"acceptedAnswer":124},"How did the study evaluate COL3A1’s role in DDP efficacy?",{"text":125,"@type":113},"Functional assays measured cell growth, invasiveness, migration, apoptosis, and DDP sensitivity, and xenograft experiments assessed COL3A1’s impact on DDP anti-tumor effects in vivo.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},337616,1790292872,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":41,"preview_page_count":19,"preview_urls":149},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","CANCER BIOLOGY & THERAPY  \n2024, VOL. 25, NO. 1, 2328382 [https://doi.org/10.1080/15384047.2024.2328382](https://doi.org/10.1080/15384047.2024.2328382)  \nRESEARCH PAPER  \nRole and mechanism of COL3A1 in regulating the growth, metastasis, and drug sensitivity in cisplatin-resistant non-small cell lung cancer cells  \nJiankun Rena, Songwei Zhaoa, and Junyu Lai b  \naNursing School, Hebi Polytechnic, Hebi City, China; bDepartment of Cardiology, Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China  \nABSTRACT  \nNon-small cell lung cancer (NSCLC) is among the most difficult malignancies to treat. Type III collagen (COL3A1) can affect the progression and chemoresistance development of NSCLC. We herein explored the mechanism that drives COL3A1 dysregulation in NSCLC. Potential RNA-binding proteins (RBPs) and transcription factors (TFs) that could bind to COL3A1 were searched by bioinformatics. mRNA expression was detected by quantitative PCR. Protein expression was evaluated using immunoblotting and immunohistochemistry. The effects of the variables were assessed by gauging cell growth, invasiveness, migratory capacity, apoptosis, and cisplatin (DDP) sensitivity. The direct YY1/COL3A1 relationship was confirmed by ChIP and luciferase reporter experiments. Xenograft experiments were done to examine COL3A1’s function in DDP efficacy. COL3A1 showed enhanced expression in DDP-resistant NSCLC. In H460/DDP and A549/DDP cells, downregulation of COL3A1 exerted inhibitory functions in cell growth, invasiveness, and migration, as well as promoting effects on cell DDP sensitivity and apoptosis. Mechanistically, ELAV-like RNA binding protein 1 (ELAVL1) enhanced the mRNA stability and expression of COL3A1, and Yin Yang 1 (YY1) promoted the transcription and expression of COL3A1 . Furthermore, upregulation of COL3A1 reversed ELAVL1 inhibition- or YY1 deficiency-mediated functions in DDPresistant NSCLC cells. Additionally, COL3A1 downregulation enhanced the anti-tumor efficacy of DDPin vivo. Our investigation demonstrates that COL3A1 upregulation, induced by both RBP ELAVL1 and TF YY1, exerts important functions in phenotypes of NSCLC cells with DDP resistance, offering an innovative opportunity in the treatment of drug-resistant NSCLC.  \nARTICLE HISTORY  \nReceived 5 December 2023 Revised 4 March 2024 Accepted 5 March 2024  \nKEYWORDS  \nNSCLC; DDP resistance; COL3A1; RNA-binding protein; transcription factor  \nIntroduction  \nAs the most prevalent subtype of malignant lung tumor, nonsmall cell lung cancer (NSCLC) is among the most difficult malignancies to treat.1 Due to the absence of clinical presentations, NSCLC patients are confirmed at the advanced stage or metastasis stage and have the poorest prognosis.2 In China, the advance of screening programs has elevated the survival rates of NSCLC due to the increase in early detection.3 Furthermore, substantial improvements in therapeutic regimens, including chemoradiotherapy and neoadjuvant chemoimmunotherapy, have resulted in a remarkable increase in survival times and transformed outcomes for numerous NSCLC cases.3 Nevertheless, chemotherapeutic regimens have limited utility in curbing these NSCLC cases with drug resistance. 1 Unveiling disease molecular biology has been generally accepted as an innovative opportunity for the development of targeted therapies against drug-resistant NSCLC.  \nType III collagen (COL3A1), a crucial member of extracellular matrix proteins, is the main structural element in various organs and is involved in fibrosis and wound healing process.4 Tumor-associated fibroblasts contribute to cancer microenvironment. Some molecules (including COL3A1) produced by these fibroblasts are related to tumorigenesis and metastasis  \nand have been found to be probable targets for cancer therapy.5 In breast cancer, radiation therapy leads toa striking elevation of COL3A1 expression.6 In gastric cancer, upregulation of COL3A1 has close relevance to poor prog","cbCairIsF2a4Nh1y","https://ap.wps.com/l/cbCairIsF2a4Nh1y","pdf",4713134,12,"English","# Abstract\n# Introduction\n## COL3A1 and NSCLC drug resistance\n## RNA-binding proteins and transcriptional regulation\n## Study aim and rationale","[{\"question\":\"What is the main focus of the research paper?\",\"answer\":\"The paper examines how COL3A1 regulates growth, metastasis, and drug sensitivity in cisplatin-resistant NSCLC cells, including the molecular mechanism behind its dysregulation.\"},{\"question\":\"How is COL3A1 expression related to cisplatin resistance in NSCLC?\",\"answer\":\"COL3A1 shows enhanced expression in DDP-resistant NSCLC, and reducing COL3A1 inhibits growth, invasion, and migration while increasing DDP sensitivity and apoptosis.\"},{\"question\":\"Which molecular regulators are implicated in controlling COL3A1?\",\"answer\":\"ELAVL1 enhances COL3A1 mRNA stability and expression, while YY1 promotes COL3A1 transcription and expression; increasing COL3A1 can counteract ELAVL1 inhibition or YY1 deficiency effects.\"},{\"question\":\"How did the study evaluate COL3A1’s role in DDP efficacy?\",\"answer\":\"Functional assays measured cell growth, invasiveness, migration, apoptosis, and DDP sensitivity, and xenograft experiments assessed COL3A1’s impact on DDP anti-tumor effects in vivo.\"}]","Role and mechanism of COL3A1 in regulating the growth, metastasis, and drug sensitivity in cisplatin-resistant non-small cell lung cancer cells | PDF",1790019825,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/555ace6743a15303451ffe9207bdcbcc.webp",983,1280,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/56f87aff7d6e0d1a56107a09e825d2c7.webp",982,1278,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/400833893bf1cd1143a681d2c7042766.webp",981,1277,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2728727c5800f8cd072efaa04d3a46aa.webp",980,1276]